Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents


1. 3,5-pyridinedicarboxylic Acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester, (4s)-, Benzenesulfonate (1:1)
2. 3-ethyl 5-methyl (4s)-2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate Benzenesulfonate (1:1)
1. 150566-71-5
2. (s)-amlodipine Besylate
3. Levamlodipine Besilate
4. (-)-amlodipine Besylate
5. Levamlodipine Besilate [who-dd]
6. S-amlodipine Benzenesulfonate
7. Levoamlodipine Besylate
8. 885h5yc40l
9. 3,5-pyridinedicarboxylic Acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester, (4s)-, Benzenesulfonate (1:1)
10. 3,5-pyridinedicarboxylic Acid, 2-((2-aminoethoxy)methyl)-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester, (4s)-, Monobenzenesulfonate
11. Benzenesulfonic Acid;3-o-ethyl 5-o-methyl (4s)-2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydropyridine-3,5-dicarboxylate
12. 3,5-pyridinedicarboxylic Acid, 2-[(2-aminoethoxy)methyl]-4-(2-chlorophenyl)-1,4-dihydro-6-methyl-, 3-ethyl 5-methyl Ester, (4s)-, Benzenesulfonate (1:1)
13. Unii-885h5yc40l
14. (s)-amlodipinebesylate
15. Hy-14744a
16. Cs-0090891
17. 129l824
18. Q27269892
19. (s)-amlodipine Besylate (103129-82-4(free Base))
20. 192583-58-7
| Molecular Weight | 567.1 g/mol |
|---|---|
| Molecular Formula | C26H31ClN2O8S |
| Hydrogen Bond Donor Count | 3 |
| Hydrogen Bond Acceptor Count | 10 |
| Rotatable Bond Count | 11 |
| Exact Mass | 566.1489648 g/mol |
| Monoisotopic Mass | 566.1489648 g/mol |
| Topological Polar Surface Area | 163 Ų |
| Heavy Atom Count | 38 |
| Formal Charge | 0 |
| Complexity | 830 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Market Place
ABOUT THIS PAGE
52
PharmaCompass offers a list of Levoamlodipine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Levoamlodipine manufacturer or Levoamlodipine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Levoamlodipine manufacturer or Levoamlodipine supplier.
A S-Amlodipine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of S-Amlodipine, including repackagers and relabelers. The FDA regulates S-Amlodipine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. S-Amlodipine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of S-Amlodipine manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A S-Amlodipine supplier is an individual or a company that provides S-Amlodipine active pharmaceutical ingredient (API) or S-Amlodipine finished formulations upon request. The S-Amlodipine suppliers may include S-Amlodipine API manufacturers, exporters, distributors and traders.
click here to find a list of S-Amlodipine suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A S-Amlodipine DMF (Drug Master File) is a document detailing the whole manufacturing process of S-Amlodipine active pharmaceutical ingredient (API) in detail. Different forms of S-Amlodipine DMFs exist exist since differing nations have different regulations, such as S-Amlodipine USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A S-Amlodipine DMF submitted to regulatory agencies in the US is known as a USDMF. S-Amlodipine USDMF includes data on S-Amlodipine's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The S-Amlodipine USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of S-Amlodipine suppliers with USDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a S-Amlodipine Drug Master File in Korea (S-Amlodipine KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of S-Amlodipine. The MFDS reviews the S-Amlodipine KDMF as part of the drug registration process and uses the information provided in the S-Amlodipine KDMF to evaluate the safety and efficacy of the drug.
After submitting a S-Amlodipine KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their S-Amlodipine API can apply through the Korea Drug Master File (KDMF).
click here to find a list of S-Amlodipine suppliers with KDMF on PharmaCompass.
S-Amlodipine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of S-Amlodipine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right S-Amlodipine GMP manufacturer or S-Amlodipine GMP API supplier for your needs.
A S-Amlodipine CoA (Certificate of Analysis) is a formal document that attests to S-Amlodipine's compliance with S-Amlodipine specifications and serves as a tool for batch-level quality control.
S-Amlodipine CoA mostly includes findings from lab analyses of a specific batch. For each S-Amlodipine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
S-Amlodipine may be tested according to a variety of international standards, such as European Pharmacopoeia (S-Amlodipine EP), S-Amlodipine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (S-Amlodipine USP).